Non-Billable / Non-Specific Code
ICD-10-CM C40 is the diagnosis code for Malignant neoplasm of bone and articular cartilage of limbs. This code falls under the section "Malignant neoplasms of bone and articular cartilage" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where C40 sits in the ICD-10-CM classification helps ensure proper coding:
No, C40 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C40 is the ICD-10-CM diagnosis code for "Malignant neoplasm of bone and articular cartilage of limbs". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C40 is located in Section C40-C41 — "Malignant neoplasms of bone and articular cartilage" within Chapter 2 of the ICD-10-CM Tabular List.
C40 has 6 sub-code(s) that provide more specific detail: C40.0, C40.1, C40.2, C40.3, C40.8 and more.
Use C40 when the patients documented diagnosis matches "Malignant neoplasm of bone and articular cartilage of limbs" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of bone and articular cartilage of limbs is C40.
No, C40 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C40 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C40 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.